Watch for next pipeline catalyst readout (likely within 1-2 quarters). The active-manager accumulation pattern at these share prices suggests institutional conviction in upcoming clinical data. Monitor additional 13F filings at next quarter for follow-through buying.
ERAS drugs
ERAS drug pipeline →How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 12 $14.05entry
- T+1 · 5mo ago +2.70%α +0.94% · $14.43
- T+5 · 5mo ago −2.70%α −3.38% · $13.67
- T+20 · 4mo ago +31.89%α +30.11% · $18.53
- T+60 · 2mo ago +15.87%α +12.61% · $16.28
How similar events traded
Executive Summary
17 institutions accumulated $24.5M in Erasca (ERAS) during 2024-Q3 (net +$9.8M vs. Q2), led by Citadel, Dimensional Fund Advisors, and Schwab. Six sellers exited or trimmed $21.2M, with Balyasny fully exiting a $10.2M position. The heavy active-manager buying alongside large quants signals conviction in Erasca's pipeline catalysts ahead of multiple near-term clinical readouts.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$11.7M
▲ Buyers (17)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Citadel | ADD | +31% | $11.8M | $4.0M |
| Dimensional Fund Advisors | DOUBLED | +141.6% | $3.3M | $2.1M |
| Schwab | ADD | +29.3% | $4.7M | $1.6M |
▼ Sellers (6)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Balyasny Asset Management | EXIT | -100% | $10.2M | -$10.2M |
| Janus Henderson Group | TRIM | -49.7% | $19.3M | -$8.1M |
| Point72 | NEAR_EXIT | -93.9% | $2.4M | -$2.3M |
Key Facts
- 17 buyers added $9.8M net vs. 6 sellers who reduced $21.2M; aggregate buyer holdings reached $24.5M
- Citadel added 1.02M shares (+31%), now holding $11.8M, the largest buyer position
- Balyasny fully exited a $10.2M position (4.32M shares)
- Janus Henderson trimmed $8.1M (49.7%), remaining at $11.2M, the largest seller
- Point72 near-exited a $2.4M position, reducing to $174K
- Dimensional Fund Advisors doubled (+142%) to 1.21M shares ($3.3M), Verition +650% to $463K
- Cluster dominated by active managers and quant funds, not passive rebalancing, higher conviction signal
Financial Impact
Institutional net buying of $9.8M in Q3 vs. $21.2M in selling, with aggregate buyer holdings of $24.5M, approximately 1-2% of float transacted
Risk Factors
- Early-stage biotech binary risk, pipeline failure would negate accumulation thesis
- 45-day filing lag; positions may have been unwound since quarter-end
- Janus Henderson and Balyasyn sell side offsets a portion of buying conviction
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-ERAS-2024-Q3 |
Track record
26 reports on ERAS
3 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +95.35% at T+60 after the Apr 27, 2026 report. 6 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $15.21 settles Feb 12
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.31 settles Feb 12
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $15.35 settles Feb 12
- Nov 12, 20264d ago Press Release Neutral 4/10 Entry $15.66 settles Feb 11
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $14.64 settles Feb 1
- Oct 16, 20264w ago 8-K Neutral 2/10 Entry $13.39 settles Jan 13
- Aug 24, 202612w ago 8-K Bullish 5/10 Entry $17.60 settles Nov 17
- Aug 17, 202613w ago 144 Neutral 3/10 Entry $18.28 to $15.61 ▼ −14.61% −11.84% vs SPY
- Aug 13, 202613w ago Institutional Cluster Bullish 6/10 Entry $17.86 to $14.41 ▼ −19.32% −13.84% vs SPY
- Aug 12, 202613w ago 3 Neutral 2/10 Entry $17.86 to $14.41 ▼ −19.32% −13.84% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers